What AOD-9604 is
AOD-9604 is a hGH fragment 176-191 analogue. A modified fragment of the C-terminus of human growth hormone, studied for lipolytic activity without the growth-promoting or insulin-antagonising profile of intact GH.
Class and mechanism
AOD-9604 is a hGH fragment 176-191 analogue. A modified fragment of the C-terminus of human growth hormone, studied for lipolytic activity without the growth-promoting or insulin-antagonising profile of intact GH.
Where it sits
Incretin compounds are grouped by how many receptors they act at. A single agonist works at GLP-1 alone, a dual agonist adds GIP, and a triple agonist adds glucagon. The receptor count is the clearest way to tell one from another when the names are unfamiliar.
Others in the metabolic and GLP-1 range
AOD-9604 sits in the metabolic and GLP-1 group. The compounds below share that grouping, which is the useful starting point when comparing one against another: same group means the comparison is like for like, different group usually means it is not.
| Compound | Class | Listings | From |
|---|---|---|---|
| Retatrutide | Triple GIP/GLP-1/glucagon receptor agonist | 4 | £160 |
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | 4 | £110 |
| Semaglutide | GLP-1 receptor agonist | 3 | £60 |
| MOTS-c | Mitochondrial-derived peptide | 2 | £60 |
| 5-Amino-1MQ | NNMT inhibitor | 2 | £40 |
| SS-31 | Mitochondria-targeted tetrapeptide | 2 | £60 |
Is it held in UK stock?
Stock held in the UK ships domestically, with no customs step. The product page carries live stock rather than a cached figure.
Quanta Pharma AOD-9604 5mgin stock£30
Availability checked 2026-09-09. The product page carries live stock.